Skip to main menu | Skip to content

  Benefits of LAAM demonstrated after its withdrawal from market!

Posted: September 13, 2005 16:51

The effects of racemic D,L-methadone and L-methadone in substituted patients - a randomized controlled study. Verthein U, Ullmann R et al. Drug and Alcohol Dependence 2005 80;2:267-271



Dear Colleagues,

This interesting and definitive study from Hamburg informs us that pure 'levomethadone' and racemic (mixed levo-dextro 50:50) methadone are clinically equivalent in the expected ratio of 1:2 with no significant difference in withdrawal symptoms or other clinical aspects of maintenance treatment. The pure enantiomer is more expensive and thus should probably be phased out in Germany, the only country where it had widespread use.

Despite no real evidence, some have speculated that certain methadone side effects might be due by the inactive L or 'dextro' component. This careful, cross-over, randomised trial with 75 subjects has only found mild, transient differences in sudden experimental substitutions of medication. These did not reach significance and confirm what was done by Judson in 1976.

Comments from Andrew Byrne ..

 

Disclaimer

On this web site, Dr Byrne and colleagues have written summaries of many research articles, conferences and other events. These have been written largely to draw attention to peer-reviewed studies which may be relevant to clinical practice and public policy. While all care has been taken to be fair and accurate, readers are strongly advised to read the original publications before acting upon the information for clinical decisions.

Due to this brief form of communication, no responsibility can be taken for errors, mistakes or omissions.

Reputable sources of health information for the general public:

© andrew byrne     +61 2 9319 5524
Valid XHTML 1.0 Transitional Mostly CSS validated but hacked for IE!